The effect of enzyme therapy in a patient with Gaucher disease type III

被引:3
作者
Bosman, DK
Hollak, CEM
Aerts, JMFG
Bakker, HD
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,EMMA CHILDRENS HOSP,NL-1105 AZ AMSTERDAM,NETHERLANDS
[2] UNIV AMSTERDAM,ACAD MED CTR,DEPT INTERNAL MED,NL-1105 AZ AMSTERDAM,NETHERLANDS
[3] UNIV AMSTERDAM,ACAD MED CTR,DEPT BIOCHEM,NL-1105 AZ AMSTERDAM,NETHERLANDS
关键词
D O I
10.1007/BF01799852
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:703 / 704
页数:2
相关论文
共 3 条
[1]   REPLACEMENT THERAPY FOR INHERITED ENZYME DEFICIENCY - MACROPHAGE-TARGETED GLUCOCEREBROSIDASE FOR GAUCHERS-DISEASE [J].
BARTON, NW ;
BRADY, RO ;
DAMBROSIA, JM ;
DIBISCEGLIE, AM ;
DOPPELT, SH ;
HILL, SC ;
MANKIN, HJ ;
MURRAY, GJ ;
PARKER, RI ;
ARGOFF, CE ;
GREWAL, RP ;
YU, KT .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21) :1464-1470
[2]  
HOLLAK CEM, 1993, NEW ENGL J MED, V328, P1565
[3]   MARKED ELEVATION OF PLASMA CHITOTRIOSIDASE ACTIVITY - A NOVEL HALLMARK OF GAUCHER DISEASE [J].
HOLLAK, CEM ;
VANWEELY, S ;
VANOERS, MHJ ;
AERTS, JMFG .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1288-1292